108 related articles for article (PubMed ID: 16156271)
1. [Effects of triptolide on anti-angiogenesis by reducing expression of urokinase plasminogen activator].
Ding Y; Zhang J; Hou L; Zhang J; Wang Q; Wang S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):778-81. PubMed ID: 16156271
[TBL] [Abstract][Full Text] [Related]
2. [Effect of triptolide on expression of urokinase-type plasminogen activators in vascular endothelial cells].
Ding Y; Zhang J; Zhao QL; Hou LJ; Wang QL; Wang SR
Ai Zheng; 2005 Jul; 24(7):801-5. PubMed ID: 16004804
[TBL] [Abstract][Full Text] [Related]
3. [Effects of triptolide on migration of vascular endothelial cells].
Ding Y; Zhao QL; Li YG; Zhang J; Wang QL; Wang SR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):347-50. PubMed ID: 15931865
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
5. Effects of triptolide and TNF-alpha on the expression of VEGF in Raji cells and on angiogenesis in ECV304 cells.
Cui GH; Chen WH; Xue KY; Liu F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1008-12. PubMed ID: 17096908
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway.
Zhu W; Ou Y; Li Y; Xiao R; Shu M; Zhou Y; Xie J; He S; Qiu P; Yan G
Mol Pharmacol; 2009 Apr; 75(4):812-9. PubMed ID: 19158360
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
8. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
9. [Expression and biological activity of human angiogenesis inhibitor angiostatin in insect cells].
Xu XL; Liu GF; Huang DY
Ai Zheng; 2005 Sep; 24(9):1096-101. PubMed ID: 16159432
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells.
Zhu W; He S; Li Y; Qiu P; Shu M; Ou Y; Zhou Y; Leng T; Xie J; Zheng X; Xu D; Su X; Yan G
Vascul Pharmacol; 2010; 52(1-2):46-54. PubMed ID: 19854299
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell response to lactate: implication of PAR modification of VEGF.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
[TBL] [Abstract][Full Text] [Related]
14. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits COX-2 expression by regulating mRNA stability in TNF-α-treated A549 cells.
Sun L; Zhang S; Jiang Z; Huang X; Wang T; Huang X; Li H; Zhang L
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):99-105. PubMed ID: 22093832
[TBL] [Abstract][Full Text] [Related]
16. Triptolide functions as a potent angiogenesis inhibitor.
He MF; Huang YH; Wu LW; Ge W; Shaw PC; But PP
Int J Cancer; 2010 Jan; 126(1):266-78. PubMed ID: 19569053
[TBL] [Abstract][Full Text] [Related]
17. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
[TBL] [Abstract][Full Text] [Related]
18. Depolymerized products of lambda-carrageenan as a potent angiogenesis inhibitor.
Chen H; Yan X; Lin J; Wang F; Xu W
J Agric Food Chem; 2007 Aug; 55(17):6910-7. PubMed ID: 17661479
[TBL] [Abstract][Full Text] [Related]
19. [Effects of triptolide on prostate carcinoma in mouse RM-1 cells].
Zhang R; Zhang PY; Guo J; Yang D; Wang WJ; Zheng MH; Ma YC
Zhonghua Nan Ke Xue; 2007 Mar; 13(3):237-41. PubMed ID: 17393788
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
Kern J; Bauer M; Rychli K; Wojta J; Ritsch A; Gastl G; Gunsilius E; Untergasser G
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):478-84. PubMed ID: 18187668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]